IDH1 and central nervous system cancer: Given MiSL's prediction in AML and glioma and the positive validation of the IDH1mut-ACACA SL relationship in AML, it seems plausible that IDH1mut-ACACA SL relationship is valid in other IDH1 mutant tumours.